[Clinical evaluation of ceftazidime and the combined administration of cefotaxime and tobramycin in the treatment of urinary tract infections. Prospective and randomized studies].
BMJ. 2004 Mar 20;328(7441):668. doi: 10.1136/bmj.38028.520995.63. Epub 2004 Mar 2.
3
Urinary alanine-aminopeptidase (AAP) excretion in patients with urinary tract infection treated with ceftazidime (CAZ) or cefotaxime (CTX) plus tobramycin (TOB).